SNOAW
Sonoma Pharmaceuticals Inc.
Halal Rating :
Last Price
$0.00
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions. The company markets its products through both direct sales and partnerships in the United States and internationally.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $3.58m | $4.43m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $3.39m | $4.56m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $3.44m | $4.85m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Sonoma Pharmaceuticals Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.